AN
Aion Therapeutic Inc.
ANTCF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $2.86M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
77 /100
Cheap P/S 1.94x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
15 /100
Weak Op. margin 104.33%
Gross margin 37.50%
FCF margin 104.95%
Quality
79 /100
Excellent Asset turnover 1.22x
ROIC 82.47%
ROA 550.85%
Debt
0 /100
High Int. coverage -19.07x
Current ratio 0.19x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 4.71x
EPS volatility 749.42%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ANTCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
John Graham Simmonds Jr.
Employees
5
Headquarters
Vancouver